Religare Broking: Aurobindo Pharma poised for next leg of rally after consolidation
“We are seeing a mixed trend within the pharma space, and Auropharma is currently sitting on the sidelines while hovering in a consolidation base. Traders can buy for a target of Rs 1300 in the next 1-2 months,” Ajit Mishra – SVP, Research, Religare Broking Ltd, said.
READ MORE:
Other News Videos
SEBI unveils Pilot DLT tokenisation project as risk evaluation process continues
Up to Rs 25 petrol, diesel hike? Oil firms still bleeding Rs 1,380 crore daily
Trendline Breakout Points to Bullish Reversal in Deepak Nitrite
Reliance Industries Q4 Results: Profit falls 13% YoY as energy margins weaken; Jio and retail shine
LIVE | Wipro Q4 results: Profit drops 1.89% on yearly basis | Earnings under pressure